1. Webinar Aug 8 2013 What‘s new in Neo4j 2.0 Michael Hunger, Neo Technology @mesirii | @neo4j 2. BIG NEWS Neo4j 2.0.0-M04 released today! 3. Neo4j 2.0 4. Why 2.0? 5. (0.x)…

Slide 1 Slide 2 X Treatment population Control population 0 Examples: Drug vs. Placebo, Drugs vs. Surgery, New Tx vs. Standard Tx Let X = decrease (–) in cholesterol level…

1.Tymoteusz MotylewskiT3DD12EXT:Community2. AOE mediaWiesbadenTYPO3 & MagentoTwitter: @tmotylMail: [email protected] Motylewski 3. • Have you played around…

1. EXT:CommunityTymoteusz MotylewskiT3DD12 2. Tymoteusz MotylewskiAOE mediaWiesbadenTYPO3 & MagentoTwitter: @tmotylMail: [email protected] 3. You?!• Have you played…

Slide 1 April 4, 2006 Reimbursement and Phase IV: CRO Role In Clearing The Fourth Hurdle Slide 2 Objective Understand trends in payer use of Phase IV studies and registries…

Slide 1 Northern Colorado Eye Center Continuing Education Event Corneal Collagen Cross-linking September 20, 2014 S. Lance Forstot, MD, FACS Corneal Consultants of Colorado…

Slide 1 Paul Y. Kwo, MD Professor of Medicine Medical Director of Transplantation Division of Medicine/Gastroenterology/ Hepatology Indiana University School of Medicine…

Chapter 4 Multiple users access the same communication channel Multi-access Communication Multiple users access the same communication channel Multiple access protocols can…

Slide 1 Overview of Biostatistical Methods 1 X Treatment population Control population 0 Overview of Biostatistical Methods Examples: Drug vs. Placebo, Drugs vs. Surgery,…

Slide 1 Overview of Biostatistical Methods 1 X Treatment population Control population 0 Overview of Biostatistical Methods Examples: Drug vs. Placebo, Drugs vs. Surgery,…